Cargando…
Synergistic effects of dendrosomal nanocurcumin and oxaliplatin on oncogenic properties of ovarian cancer cell lines by down-expression of MMPs
BACKGROUND: Contrary to the advantageous anticancer activities of curcumin (Cur), limited bioavailability and solubility hindered its efficacy. Here, nontoxic dendrosomal nano carrier with Cur was used to overcome these problems. Despite considerable antitumor properties of Oxaliplatin (Oxa), the li...
Autores principales: | Seyed Hosseini, Elahe, Alizadeh Zarei, Marziyeh, Tarrahimofrad, Hossein, Zamani, Javad, Haddad Kashani, Hamed, Ahmad, Ejaz, Nikzad, Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854214/ https://www.ncbi.nlm.nih.gov/pubmed/36658640 http://dx.doi.org/10.1186/s40659-023-00412-x |
Ejemplares similares
-
Effects of the exercise-inducible myokine irisin on proliferation and malignant properties of ovarian cancer cells through the HIF-1 α signaling pathway
por: Alizadeh Zarei, Marziyeh, et al.
Publicado: (2023) -
Dendrosomal nanocurcumin and p53 overexpression synergistically trigger apoptosis in glioblastoma cells
por: Keshavarz, Reihaneh, et al.
Publicado: (2016) -
The impact of LncRNA dysregulation on clinicopathology and survival of pancreatic cancer: a systematic review and meta-analysis (PRISMA compliant)
por: Seyed Hosseini, Elahe, et al.
Publicado: (2021) -
An investigation of the inhibitory effects of dendrosomal nanocurcumin on Candida albicans and systemic candidiasis in BALB/c mice
por: Katiraee, F, et al.
Publicado: (2016) -
Molecular and Clinical Investigation of COVID-19: From Pathogenesis and Immune Responses to Novel Diagnosis and Treatment
por: Kashani, Narjes Riahi, et al.
Publicado: (2022)